UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Schedule 14A
Proxy Statement Pursuant to Section 14(a) of
the
Securities Exchange Act
of 1934
Filed by the Registrant ☒
Filed by a party other than the Registrant ☐
Check the appropriate box:
☐ |
Preliminary Proxy Statement |
☐ |
Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) |
☐ |
Definitive Proxy Statement |
☒ |
Definitive Additional Materials |
☐ |
Soliciting Material Under §240.14a-12 |
EOS ENERGY ENTERPRISES, INC.
(Exact Name of Registrant as Specified in Its Charter)
(Name of Person(s) Filing Proxy Statement, if other
than the Registrant)
Payment of Filing Fee (Check the appropriate box):
☐ |
Fee paid previously with preliminary materials. |
☐ |
Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a6(i)(1) and 0-11. |
Eos Energy Enterprises, Inc.
3920 Park Avenue
Edison, New Jersey 08820
SUPPLEMENT TO THE PROXY STATEMENT FOR THE ANNUAL
MEETING OF STOCKHOLDERS TO BE HELD ON SEPTEMBER 10, 2024
Unless the context otherwise requires, references
in this proxy statement supplement (this “Supplement”) to “Eos,” the “Company,” “we,”
“us,” or “our,” refer to Eos Energy Enterprises, Inc., a Delaware corporation.
The following information supplements and amends the
Definitive Proxy Statement on Schedule 14A (the “Proxy Statement”) that was filed by the Company with the Securities and Exchange
Commission (the “SEC”) on August 8, 2024 and furnished to the Company’s stockholders in connection with the solicitation
of proxies by the Company’s Board of Directors (the “Board”) for the Company’s 2024 special meeting of stockholders
(the “Special Meeting”) and any postponement(s) or adjournment(s) thereof. This Supplement is being filed with the SEC and
being made available to stockholders on or about September 3, 2024. All capitalized terms not otherwise defined herein shall have their
respective meanings as set forth in the Proxy Statement.
As previously disclosed, on June 21, 2024, Eos
Energy Enterprises, Inc. (the “Company”) entered into a credit and guaranty agreement (the “Credit Agreement”),
by and among the Company, certain of the Company’s subsidiaries as guarantors party thereto, CCM Denali Debt Holdings, LP, acting
through Cerberus Capital Management II, L.P. (“Cerberus”), as administrative agent and collateral agent and the lenders party
thereto from time to time (the “Lenders”), pursuant to which the Lenders have provided a $210.5 million secured multi-draw
facility (the “Delayed Draw Term Loan”), and a $105 million revolving credit facility, to be made available at the Lenders’
sole discretion and only if the Delayed Draw Term Loan is fully funded (the “Revolving Facility” and together with the Delayed
Draw Term Loan, the “Facilities”), on terms and subject to conditions set forth in the Credit Agreement.
Upon each draw under the Delayed Draw Term Loan,
the Company will issue Warrants and/or Preferred Stock (each as defined in the Proxy Statement) in amounts representing predetermined,
fully diluted, percentages (an “Applicable Percentage”) of Company common stock, par value $0.0001 per share (the “Common
Stock”). Upon any failure to achieve a milestone, in addition to not being able to receive a draw on the Delayed Draw Term Loan
unless waived by the Lenders, the Applicable Percentage will be subject to up to a 4.0% increase for all milestone events as to each of
the four milestone measurement dates.
On August 28, 2024, the Company and Cerberus mutually
confirmed that the Company satisfied all four applicable performance milestones comprising the first milestone (the “First Milestone”)
ahead of the August 31, 2024 milestone measurement date (the “First Milestone Measurement Date”), related to the Company’s
automated line, materials cost, Z3 technology and backlog/cash conversion, pursuant to the terms of the Credit Agreement. On August 29,
2024, the Company submitted a borrowing request under the Credit Agreement, and the Lenders funded the full amount of the scheduled $30
million draw under the Delayed Draw Term Loan.
In connection with the additional draw and pursuant
to the terms and conditions of that certain Securities Purchase Agreement (the “Securities Purchase Agreement”), dated June
21, 2024, by and between the Company and Cerberus, the Applicable Percentage increased by 4.9%, and as a result the Company issued to
Cerberus 7 shares of a newly designated Series A-2 Preferred Stock, par value $0.0001 per share (the “Series A-2 Preferred Stock”),
with the number of shares of such series having a liquidation value as if such shares were convertible into an aggregate of 28,806,463
shares of Common Stock. Collectively, the Initial Warrant issued on June 21, 2024 and the liquidation values of the Series A-1 Preferred
Stock issued on June 21, 2024 and the Series A-2 Preferred Stock equate to 104,022,720 shares of Common Stock, or an Applicable Percentage
of 24.8%. If Stockholder Approval is obtained, the Series A-2 Preferred Stock will be convertible into a number of shares of Series B-2
Preferred Stock, par value $0.0001 per share (“Series B-2 Preferred Stock”) that are convertible into an equal number of shares
of Common Stock as then represented by the liquidation value of the Series A-2 Preferred Stock.
The Certificate of Designation for the Series
A-2 Preferred Stock contains substantially similar terms to the Series A-1 Preferred Stock Certificate of Designation except that under
the terms of the Series A-2 Certificate of Designation, each share of Series A-2 Preferred Stock has an original issue price of $9,555,515.30
(the “A-2 Original Issue Price”) and a liquidation value, payable pari passu with the Common Stock, as if such share was convertible
into 4,115,209 shares, or an aggregate of 28,806,463 shares of Common Stock, subject to adjustment. The Series A-2 Preferred Stock will
become convertible into shares of Series B-2 Preferred Stock if Stockholder Approval is obtained.
If Cerberus, as the purchaser, funds all draws
under the Delayed Draw Term Loan and the Company meets each of the remaining milestones under the Delayed Draw Term Loan, Cerberus will
be entitled to receive Preferred Stock or Warrants aggregating to an Applicable Percentage of 33.0% or assuming the number of our outstanding
shares of Common Stock on a fully diluted basis does not change after August 29, 2024, Preferred Stock and Warrants with respect to an
aggregate of 155,357,957 shares of Common Stock, including the Initial Warrant, Series A-1 Preferred Stock and Series A-2 Preferred Stock
already issued to Cerberus. If Stockholder Approval is obtained, such shares of Preferred Stock and Warrants would be directly or indirectly
convertible into or exercisable for shares of Common Stock, subject only to a beneficial ownership cap of 49.9% of the issued and outstanding
Common Stock of the Company.
As a result of meeting the First Milestone, if
Cerberus funds all draws under the Delayed Draw Term Loan and the Company fails to meet all of the remaining milestones under the Delayed
Draw Term Loan, Cerberus would be entitled to receive Preferred Stock or Warrants aggregating to a maximum Applicable Percentage of 45.0%
(previously 49.0%), or assuming the number of our outstanding shares of Common Stock on a fully diluted basis does not change after August
29, 2024, Preferred Stock and Warrants with respect to an aggregate of 258,073,962 shares of Common Stock, including the Initial Warrant,
Series A-1 Preferred Stock and Series A-2 Preferred Stock already issued to Cerberus. If Stockholder Approval is obtained such shares
of Preferred Stock and Warrants would be directly or indirectly convertible into or exercisable for shares of Common Stock, subject only
to a beneficial ownership cap of 49.9% of the issued and outstanding Common Stock of the Company.
The information in this Supplement is in addition
to the information provided by the Proxy Statement, and except for the changes herein, this Supplement does not modify any other information
set forth in the Proxy Statement.
THE PROXY STATEMENT CONTAINS IMPORTANT ADDITIONAL
INFORMATION, AND THIS SUPPLEMENT SHOULD BE READ IN CONJUNCTION WITH THE PROXY STATEMENT.
Important Information and Where You Can
Find It
In connection with obtaining the requisite Stockholder
Approval, the Company filed the Proxy Statement on August 8, 2024, which is available at the SEC’s website (http://www.sec.gov)
and has been sent to the stockholders of the Company, seeking certain approvals related to the issuance to Cerberus of more than 19.99%
of our outstanding Common Stock.
INVESTORS AND SECURITY HOLDERS OF THE COMPANY
AND ITS RESPECTIVE AFFILIATES ARE URGED TO READ THE PROXY STATEMENT, THIS SUPPLEMENT AND ANY OTHER RELEVANT DOCUMENTS FILED OR TO BE FILED
WITH THE SEC IN CONNECTION WITH OBTAINING STOCKHOLDER APPROVAL, AS WELL AS ANY FUTURE AMENDMENTS OR SUPPLEMENTS TO THOSE DOCUMENTS, BECAUSE
THEY WILL CONTAIN IMPORTANT INFORMATION ABOUT THE COMPANY AND OBTAINING STOCKHOLDER APPROVAL. Investors and security holders will be able
to obtain a free copy of the Proxy Statement, this Supplement as well as other relevant documents filed with the SEC containing information
about the Company, without charge, at the SEC’s website (http://www.sec.gov). Copies of documents filed with the SEC can also be
obtained, without charge, by directing a request to Investor Relations, Eos Energy Enterprises, Inc. at 862-207-7955 or email ir@eose.com.
Participants in the Solicitation of Proxies
in Connection with Obtaining Stockholder Approval
The Company and certain of its respective directors,
executive officers and employees may be deemed under the rules of the SEC to be participants in the solicitation of proxies with respect
to the obtaining the requisite Stockholder Approval. Information regarding the Company directors and officers is available in (i) its
definitive proxy statement for the 2024 annual stockholders meeting, which was filed with the SEC on April 2, 2024, and (ii) its current
reports on Form 8-K filed by the Company on June 24, 2024, and July 29, 2024. Other information regarding the participants in the solicitation
of proxies in respect to Stockholder Approval and the description of their direct and indirect interests, as security holders or otherwise,
is contained in the Proxy Statement and other relevant materials to be filed by the Company with the SEC. Free copies of these documents,
when available, may be obtained as described in the preceding paragraph.
Proxy Card
The proxy card included with the Proxy Statement
remains valid, and we will not make available or distribute, and you do not need to submit, a new proxy card or provide new voting instructions
solely as a result of the updates provided for in this Supplement. All proxy cards and voting instructions returned by stockholders will
be voted at the Special Meeting unless revoked. If you have already submitted a proxy and do not wish to change your vote, no further
action is required. If you have submitted a proxy and wish to change your vote, you may revoke your proxy and change your vote as described
under “Can I change my vote after submitting my proxy?” on page 17 of the Proxy Statement.
Eos Energy Enterprises (NASDAQ:EOSE)
Historical Stock Chart
From Oct 2024 to Nov 2024
Eos Energy Enterprises (NASDAQ:EOSE)
Historical Stock Chart
From Nov 2023 to Nov 2024